Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Balanced Hormone Health vs Coivas

Balanced Hormone Health
Graded #388

Lower grade

vs+8.400000000000006
Coivas
Graded #197

Higher grade

The verdict

Coivas takes it — 66.2/100 to 57.8/100.

Coivas grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Coivas is an all-inclusive GLP-1 telehealth service operated by WellVi LLC (d/b/a Coivas) with prescriptions through Arora Health & Aesthetics, LLC.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoivas +25
45
70
Dose & formulationCoivas +11
53
64
Clinical oversightCoivas +4
80
84
Labs & monitoringEven
54
54
FulfillmentCoivas +16
62
78
Contract termsBalanced Hormone Health +35
55
20
Balanced Hormone Health · left barCoivas · right bar

The numbers

MetricBalanced Hormone HealthCoivas
WeighScore57.8/10066.2/100
GradeCC
Scorecard rank#388#197
SemaglutideNot disclosed$149/mo (quarterly plan, compounded)
TirzepatideNot disclosed$229/mo (quarterly plan, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Balanced Hormone Health

Graded #388 · C

Strengths

  • Offers compounded semaglutide and tirzepatide plus GLP-1/GIP combo plans
  • Also lists a branded Zepbound prescription option
  • Rooted in hormone health (HRT/BHRT) for a whole-metabolic approach
  • Compounded formulas often paired with B vitamins
  • Provides receipts for HSA/HRA reimbursement

Where it loses points

  • Private-pay only; does not bill insurance
  • Compounded GLP-1 is not an FDA-approved finished drug
  • Some states excluded depending on the compounding pharmacy used
  • No transparent public monthly pricing readily listed
  • Pharmacy manufacturing adds roughly a week before shipment
Coivas

Graded #197 · C

Strengths

  • All-inclusive pricing: one price covers doctor consult, prescription, shipping and support
  • Compounded semaglutide from $149/mo and tirzepatide from $229/mo on the quarterly plan
  • Names its clinical provider (Arora Health & Aesthetics, LLC) and cites USP 797 / NABP-accredited pharmacies
  • Available in all 50 states; 24/7 support; HSA/FSA eligible; money-back guarantee
  • Most patients approved in under 2 hours; refund if no provider visit or prescription occurs

Where it loses points

  • Dispensing pharmacies described only by category (503A/503B, NABP-accredited) - not named individually
  • Lower quarterly headline price requires a 3-month commitment; monthly plan costs more ($179/$289)
  • Money-back guarantee has strict adherence/verification conditions and no partial/prorated refunds
  • No brand-name Wegovy/Zepbound/Mounjaro/Ozempic - compounded injectable only; binding NY arbitration

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard